L -5-Hydroxytryptophan treatment of sleep terrors in children
L -5-Hydroxytryptophan treatment of sleep terrors in children
Bruni et al., 2004 | Eur J Pediatr | Rct
Citation
Bruni Oliviero, Ferri Raffaele, ... Verrillo Elisabetta. L -5-Hydroxytryptophan treatment of sleep terrors in children. Eur J Pediatr. 2004-Jul;163(7):402-7
Abstract
UNLABELLED: To test the hypothesis that the administration of L -5-hydroxytryptophan (L -5-HTP) might exert beneficial effects on sleep terrors, we carried out an open pharmacological trial in a group of children with sleep terrors compared to a group of children with the same disorder but without L -5-HTP treatment. Participants in the trial were 45 children (34 males and 11 females; age range 3.2-10.6 years), referred to the Sleep Centre of the Department of Developmental Neurology and Psychiatry of the University of Rome "La Sapienza", affected by sleep terrors. All subjects underwent: (1) complete medical and sleep history; (2) complete neurological examination and EEG recording whilst awake and sleeping, (3) a structured sleep diary for 2 months, (4) after 1 month, all subjects were examined again from the clinical and EEG points of view and (5) after 6 months, a structured interview in order to evaluate the clinical outcome. After the first visit, L -5-HTP was administered (2 mg/kg per day) at bedtime to 31 randomly selected patients for a single period of 20 consecutive days. After 1 month of treatment, 29/31 (93.5%) of patients showed a positive response. In the comparison group without drug therapy, after 1 month, the episodes disappeared only in four children (28.6%) while ten children (71.4%) showed the persistence of episodes with the same frequency as before. After 6 months, 26/31 (83.9%) of children treated with L -5HTP were sleep terror-free, while in five children (16.1%) sleep terror episodes persisted. Of the children in the comparison group, ten (71.4%) continued to show sleep terrors at 6-month follow-up. CONCLUSION: to our knowledge, this is the first study demonstrating the efficacy of a new drug treatment for sleep terrors. These results confirm our initial hypothesis and represent evidence that treatment with L -5-hydroxytryptophan is able to modulate the arousal level in children and to induce a long-term improvement of sleep terrors.
Key Findings
to our knowledge, this is the first study demonstrating the efficacy of a new drug treatment for sleep terrors. These results confirm our initial hypothesis and represent evidence that treatment with L -5-hydroxytryptophan is able to modulate the arousal level in children and to induce a long-term improvement of sleep terrors.
Outcomes Measured
- Requires manual extraction
Population
| Field | Value |
|---|---|
| Population | See abstract |
| Sample Size | See abstract |
| Age Range | See abstract |
| Condition | sleep |
MeSH Terms
- 5-Hydroxytryptophan
- Child
- Child, Preschool
- Female
- Follow-Up Studies
- Humans
- Male
- Night Terrors
- Treatment Outcome
Evidence Classification
- Level: Rct
- Publication Types: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial
- Vertical: 5-htp
Provenance
- PMID: 15146330
- DOI: (not available)
- PMCID: Not in PMC
- Verified: 2026-04-10 via PubMed E-utilities API
Source extracted via PubMed E-utilities API on 2026-04-10